Last viewed: DGX


Prices are updated after-hours



nyse:DGX Quest Diagnostics Incorporated

DGX | $160.15 | twitter stocktwits trandingview |
Health Services

(0.0% 1d) (10.6% 1m) (27.6% 1y) (0.0% 2d) (0.0% 3d) (2.0% 7d) (13.71% volume)
http://www.questdiagnostics.com
Sec Filling | Patents | 47000 employees

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

add to today's watch list email alert is off




clinical trials   diagnostics   information technology  

Press-releases


Health Screening Market Size, Share, Trends, Growth and Grow at 11.9% CAGR is Expected to Reach USD 541,934.11 million till 2028
Published: 2021-12-01 (Crawled : 08:00) - prnewswire.com
RDNT | $28.53 | twitter stocktwits trandingview |
Health Services
| | O: 2.7% H: 0.94% C: -5.14%
NTRA | $96.59 | twitter stocktwits trandingview |
Health Services
| | O: -0.89% H: 1.77% C: -2.78%
DGX | $160.15 | twitter stocktwits trandingview |
Health Services
| | O: -3.77% H: 3.8% C: 1.5%
EXAS | News | $86.26 | twitter stocktwits trandingview |
Health Technology
| | O: -0.58% H: 0.69% C: -6.26%
QDEL | $142.65 | twitter stocktwits trandingview |
Health Technology
| | O: -3.38% H: 1.28% C: -0.81%

growth
Quest Diagnostics Now Offers Biocept's Liquid Biopsy Test for Lung Cancer, Expanding its Menu of Advanced Cancer Diagnostics
Published: 2021-12-01 (Crawled : 15:00) - biospace.com/
DGX | $160.15 | twitter stocktwits trandingview |
Health Services
| | O: -3.77% H: 3.8% C: 1.5%
BIOC | $4.22 | twitter stocktwits trandingview |
Health Services
| | O: 2.53% H: 8.53% C: -4.44%

diagnostic diagnostics lung cancer test cancer
Organ Transplant Diagnostics Market, 2031 - Emergence of Nucleic Acid Amplification Testing (NAAT) & Growing Focus on Molecular HLA Typing
Published: 2021-11-25 (Crawled : 12:00) - prnewswire.com
QGEN | $54.76 | twitter stocktwits trandingview |
Health Technology

ILMN | $375.98 | twitter stocktwits trandingview |
Health Technology

CDNA | $45.86 | twitter stocktwits trandingview |
Health Technology

ABT | News | $132.37 | twitter stocktwits trandingview |
Health Technology

DGX | $160.15 | twitter stocktwits trandingview |
Health Services

QGEN | $54.76 | twitter stocktwits trandingview |
Health Technology

TMO | News | $638.15 | twitter stocktwits trandingview |
Health Technology

LH | $296.83 | twitter stocktwits trandingview |
Health Services

BIO | $770.22 | twitter stocktwits trandingview |
Health Technology

diagnostic test molecular growing diagnostics merge
Majority of Physicians Worry Signs of Addiction Were Missed During Pandemic, Finds New Quest Diagnostics Health Trends® Report
Published: 2021-11-15 (Crawled : 12:00) - prnewswire.com
DGX | $160.15 | twitter stocktwits trandingview |
Health Services
| | O: 0.51% H: 0.49% C: -2.16%

diagnostics
Revenue Cycle Management (RCM) Market size worth $ 249.44 Billion, Globally, by 2028 at 11.22% CAGR: Verified Market Research®
Published: 2021-11-02 (Crawled : 15:15) - prnewswire.com
DGX | $160.15 | twitter stocktwits trandingview |
Health Services
| | O: 0.52% H: 0.14% C: -2.59%
MCK | News | $226.68 | twitter stocktwits trandingview |
Distribution Services
| | O: 3.9% H: 2.74% C: 1.26%
RCM | $25.25 | twitter stocktwits trandingview |
Commercial Services
| | O: 5.12% H: 7.61% C: 4.78%
CERN | News | $73.99 | twitter stocktwits trandingview |
Technology Services
| | O: 0.1% H: 0.94% C: 0.41%

research
Quest Diagnostics Reports Third Quarter 2021 Financial Results, Raises Outlook for Full Year 2021
Published: 2021-10-21 (Crawled : 11:00) - prnewswire.com
IQV | $272.19 | twitter stocktwits trandingview |
Health Services
| | O: -0.6% H: 2.29% C: 1.94%
DGX | $160.15 | twitter stocktwits trandingview |
Health Services
| | O: 0.47% H: 1.09% C: -1.48%

financial results results diagnostics
Quest Diagnostics to Introduce Ki-67 IHC MIB-1 pharmDx, the First Companion Diagnostic for Eli Lilly and Company's Verzenio® (abemaciclib), a CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer
Published: 2021-10-18 (Crawled : 18:00) - biospace.com/
LLY | $244.32 | twitter stocktwits trandingview |
Health Technology
| | O: 0.14% H: 1.98% C: 0.43%
A | News | $156.31 | twitter stocktwits trandingview |
Health Technology
| | O: 0.23% H: 1.17% C: 0.75%
DGX | $160.15 | twitter stocktwits trandingview |
Health Services
| | O: -0.18% H: 1.13% C: 1.04%

ema risk cancer breast cancer diagnostics her2+
Quotient Limited Announces Appointment of Chief Financial Officer
Published: 2021-10-12 (Crawled : 13:00) - globenewswire.com
QTNT | $2.25 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 5.61% C: 3.16%
DGX | $160.15 | twitter stocktwits trandingview |
Health Services
| | O: 0.12% H: 1.08% C: -0.04%


Quest Diagnostics Debuts Next-Generation Lab Facility in Clifton, NJ
Published: 2021-10-12 (Crawled : 12:00) - biospace.com/
DGX | $160.15 | twitter stocktwits trandingview |
Health Services
| | O: 0.12% H: 1.08% C: -0.04%

diagnostics
Global In-vitro Toxicology Testing Market 2021-2028 - Ongoing Developments & Rise in Government Funding for Toxicology Research
Published: 2021-10-11 (Crawled : 14:00) - prnewswire.com
DHR | News 6 d | $318.26 | twitter stocktwits trandingview |
Health Technology
| | O: -0.16% H: 1.06% C: -0.19%
CRL | News | $365.96 | twitter stocktwits trandingview |
Commercial Services
| | O: -0.71% H: 1.19% C: 0.37%
CTLT | $127.46 | twitter stocktwits trandingview |
Health Technology
| | O: -0.64% H: 0.52% C: -0.76%
DGX | $160.15 | twitter stocktwits trandingview |
Health Services
| | O: 0.05% H: 0.24% C: -1.15%
LH | $296.83 | twitter stocktwits trandingview |
Health Services
| | O: -0.3% H: 0.19% C: -1.19%
BIO | $770.22 | twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 0.88% C: -0.19%

funding ongoing test research
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying